• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩洛哥全国医院血栓预防评估与管理:Avail-MoNa 研究。

Evaluation and management of thromboprophylaxis in Moroccan hospitals at national level: the Avail-MoNa study.

机构信息

Department of Internal Medicine/Hematology, Ibn Sina University Hospital, Rabat, Morocco.

Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.

出版信息

J Thromb Thrombolysis. 2018 Jul;46(1):113-119. doi: 10.1007/s11239-018-1657-7.

DOI:10.1007/s11239-018-1657-7
PMID:29651665
Abstract

Venous thromboembolism (VTE) is a common clinical problem that is associated with substantial morbidity and mortality. The aim of this study was to describe the clinical practices in VTE prophylaxis in university and peripheral hospitals in Morocco. This is a national, cross-sectional, multicenter, observational study assessing the management of the VTE risk in selected Moroccan hospitals (four university and three peripheral). The thromboembolic risk of the selected patients was assessed according to the American College of Chest Physicians (ACCP) guidelines (2008). We hypothesized that interventions for VTE guideline implementation in those hospitals may improve prophylaxis use for hospitalized patients. A total of 1318 patients were analyzed: 467 (35.5%) medical and 851 (64.5%) surgical. The mean age of patients was 52.6 ± 16.5 years, and 52.7% were female. A total of 51.1% patients were considered to be at risk of VTE according to ACCP guidelines and were eligible for thromboprophylaxis (TP). Medical patients were more likely to present risk factors than surgical patients (53.6 vs. 50.7%, respectively). TP was prescribed for 53.1% of these patients, 57.4% in at-risk surgical patients and 50.3% in at-risk medical patients. TP was also prescribed for 42.9% of non-at-risk patients. The concordance between the recommended and the prescribed prophylaxis was poor for the total population (kappa = 0.110). TP did not improve sufficiently in our hospitals, even after implementation of the guidelines. New strategies are required to appropriately address TP in hospitalized patients.

摘要

静脉血栓栓塞症(VTE)是一种常见的临床问题,与大量发病率和死亡率相关。本研究的目的是描述摩洛哥大学和外围医院 VTE 预防的临床实践。这是一项全国性、横断面、多中心、观察性研究,评估了选定摩洛哥医院(四所大学和三所外围医院)中 VTE 风险的管理。根据美国胸科医师学会(ACCP)指南(2008 年)评估选定患者的血栓栓塞风险。我们假设这些医院中 VTE 指南实施的干预措施可能会改善住院患者的预防措施使用。共分析了 1318 名患者:467 名(35.5%)内科和 851 名(64.5%)外科。患者的平均年龄为 52.6±16.5 岁,52.7%为女性。根据 ACCP 指南,共有 51.1%的患者被认为存在 VTE 风险,有资格接受血栓预防(TP)。内科患者比外科患者更有可能出现危险因素(分别为 53.6%和 50.7%)。这些患者中有 53.1%接受了 TP,其中 57.4%为高危外科患者,50.3%为高危内科患者。42.9%的非高危患者也接受了 TP。建议的预防措施与处方预防措施之间的一致性对总人群而言较差(kappa=0.110)。即使在指南实施后,我们医院的 TP 也没有得到充分改善。需要采取新策略来妥善解决住院患者的 TP 问题。

相似文献

1
Evaluation and management of thromboprophylaxis in Moroccan hospitals at national level: the Avail-MoNa study.摩洛哥全国医院血栓预防评估与管理:Avail-MoNa 研究。
J Thromb Thrombolysis. 2018 Jul;46(1):113-119. doi: 10.1007/s11239-018-1657-7.
2
Thromboprophylaxis use and concordance with guidelines among medical and surgical patients in Morocco.摩洛哥内科和外科患者的血栓预防用药情况及与指南的一致性。
Thromb Res. 2014 May;133(5):725-8. doi: 10.1016/j.thromres.2014.01.036. Epub 2014 Feb 4.
3
Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study.瑞士一项全球观察性研究的结果,该研究调查了急性护理医院环境中的静脉血栓栓塞风险和预防用药情况:来自 ENDORSE 研究的分析。
Swiss Med Wkly. 2009 Oct 31;139(43-44):630-5. doi: 10.4414/smw.2009.12746.
4
Venous thromboembolism risk assessment and thromboprophylaxis among hospitalized acute medical patients in China--the RAMP study.中国住院急性内科患者静脉血栓栓塞风险评估和血栓预防 - RAMP 研究。
Thromb Res. 2010 Oct;126(4):270-5. doi: 10.1016/j.thromres.2010.06.029. Epub 2010 Aug 4.
5
Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study.亚洲内科重症监护病房患者静脉血栓栓塞症预防(VOICE Asia):一项多中心、观察性、横断面研究。
Thromb Res. 2012 Apr;129(4):e152-8. doi: 10.1016/j.thromres.2012.01.012. Epub 2012 Feb 11.
6
Venous thromboembolism risk assessment, prophylaxis practices and interventions for its improvement (AVAIL-ME Extension Project, Iran).静脉血栓栓塞风险评估、预防措施及其改进干预(伊朗AVAIL-ME扩展项目)
Thromb Res. 2014 Apr;133(4):567-73. doi: 10.1016/j.thromres.2014.01.006. Epub 2014 Jan 11.
7
Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study.老年医院获得性静脉血栓栓塞患者对血栓预防指南的依从性:一项病例对照研究。
J Thromb Thrombolysis. 2017 Feb;43(2):172-178. doi: 10.1007/s11239-016-1432-6.
8
A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.对出院后发生静脉血栓栓塞症的患者进行血栓预防治疗的回顾性研究。
N Z Med J. 2010 Feb 19;123(1309):37-49.
9
Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients.美国医院住院患者的血栓预防治疗应用:对存在风险的内科和外科患者的第七版美国胸科医师学会推荐治疗方案的依从性。
J Hosp Med. 2009 Oct;4(8):E15-21. doi: 10.1002/jhm.526.
10
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.应用 APEX 标准评估美国医院中静脉血栓栓塞风险的急性病医疗患者是否适合延长血栓预防治疗。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619880008. doi: 10.1177/1076029619880008.

引用本文的文献

1
Venous Thromboembolism Risk and Adherence to Pharmacological Thromboprophylaxis in Hospitalized Patients in Uruguay: First Nationwide Study.乌拉圭住院患者静脉血栓栓塞风险与药物性血栓预防治疗的依从性:首个全国性研究。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241256368. doi: 10.1177/10760296241256368.
2
An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta-analysis.从世界血栓日指导委员会获取的全球患有内科疾病住院患者应用风险评估模型和血栓预防的最新信息:系统评价和荟萃分析。
J Thromb Haemost. 2022 Feb;20(2):409-421. doi: 10.1111/jth.15607. Epub 2021 Dec 13.
3

本文引用的文献

1
Reducing the incidence of hospital-associated venous thromboembolism within a network of academic hospitals: Findings from five University of California medical centers.降低学术医院网络中医院相关性静脉血栓栓塞的发生率:来自加利福尼亚大学五个医学中心的研究结果。
J Hosp Med. 2016 Dec;11 Suppl 2:S22-S28. doi: 10.1002/jhm.2658.
2
Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial.预防急性内科疾病住院患者静脉血栓栓塞的多方面干预措施:一项多中心整群随机试验
PLoS One. 2016 May 26;11(5):e0154832. doi: 10.1371/journal.pone.0154832. eCollection 2016.
3
Once-daily vs. twice-daily dosing of enoxaparin for the management of venous thromboembolism: A systematic review and meta-analysis.
依诺肝素每日一次与每日两次给药用于静脉血栓栓塞管理的系统评价和荟萃分析。
Exp Ther Med. 2020 Oct;20(4):3084-3095. doi: 10.3892/etm.2020.9036. Epub 2020 Jul 24.
Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial.
用于抗血栓预防决策的帕多瓦预测评分或临床判断:一项半随机对照试验。
J Thromb Thrombolysis. 2016 Oct;42(3):336-9. doi: 10.1007/s11239-016-1358-z.
4
Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England.普通外科出院后静脉血栓栓塞风险及相关死亡率:一项基于英格兰医院与基层医疗数据关联的人群队列研究
PLoS One. 2015 Dec 29;10(12):e0145759. doi: 10.1371/journal.pone.0145759. eCollection 2015.
5
Thromboprophylaxis use and concordance with guidelines among medical and surgical patients in Morocco.摩洛哥内科和外科患者的血栓预防用药情况及与指南的一致性。
Thromb Res. 2014 May;133(5):725-8. doi: 10.1016/j.thromres.2014.01.036. Epub 2014 Feb 4.
6
Educational outreach visits to improve venous thromboembolism prevention in hospitalised medical patients: a prospective before-and-after intervention study.教育外展访问以改善住院内科患者的静脉血栓栓塞预防:一项前瞻性干预前后研究。
BMC Health Serv Res. 2013 Oct 8;13:398. doi: 10.1186/1472-6963-13-398.
7
Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target.与住院相关的致命静脉血栓栓塞症:一项评估国家风险评估目标影响的队列研究。
Heart. 2013 Dec;99(23):1734-9. doi: 10.1136/heartjnl-2013-304479. Epub 2013 Sep 15.
8
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
9
The implementation of NICE guidance on venous thromboembolism risk assessment and prophylaxis: a before-after observational study to assess the impact on patient safety across four hospitals in England.NICE 指导意见关于静脉血栓栓塞风险评估和预防的实施:一项在英格兰 4 家医院进行的前后观察性研究,以评估对患者安全的影响。
BMC Health Serv Res. 2013 Jun 4;13:203. doi: 10.1186/1472-6963-13-203.
10
A clinical decision support system for venous thromboembolism prophylaxis at a general hospital in a middle-income country.在中等收入国家的一家综合医院中,一个用于静脉血栓栓塞预防的临床决策支持系统。
J Bras Pneumol. 2013 Mar-Apr;39(2):138-46. doi: 10.1590/s1806-37132013000200004.